402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells - Neuzillet, C.; Serova, M.; Raballand, A.; Astorgues-Xerri, L.; Riveiro, M.E.; de Gramont, A.; Ruszniewski, P.; Hammel, P.; Faivre, S.; Raymond, E. (European Journal of Cancer, 2012)